These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27492648)

  • 1. Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome.
    Blake MR; Raker JM; Whelan K
    Aliment Pharmacol Ther; 2016 Oct; 44(7):693-703. PubMed ID: 27492648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bristol Stool Form Scale reliability and agreement decreases when determining Rome III stool form designations.
    Chumpitazi BP; Self MM; Czyzewski DI; Cejka S; Swank PR; Shulman RJ
    Neurogastroenterol Motil; 2016 Mar; 28(3):443-8. PubMed ID: 26690980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modest Conformity Between Self-Reporting of Bristol Stool Form and Fecal Consistency Measured by Stool Water Content in Irritable Bowel Syndrome and a FODMAP and Gluten Trial.
    Nordin E; Hellström PM; Brunius C; Landberg R
    Am J Gastroenterol; 2022 Oct; 117(10):1668-1674. PubMed ID: 36087104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome.
    Vijayvargiya P; Camilleri M; Burton D; Busciglio I; Lueke A; Donato LJ
    Aliment Pharmacol Ther; 2019 Mar; 49(6):744-758. PubMed ID: 30740753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stool characteristics and colonic transit in irritable bowel syndrome: evaluation at two time points.
    Shim L; Talley NJ; Boyce P; Tennant C; Jones M; Kellow JE
    Scand J Gastroenterol; 2013 Mar; 48(3):295-301. PubMed ID: 23320464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Episodic nature of symptoms in irritable bowel syndrome.
    Palsson OS; Baggish J; Whitehead WE
    Am J Gastroenterol; 2014 Sep; 109(9):1450-60. PubMed ID: 24980882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of commonly used pediatric stool scales: a pilot study.
    Saps M; Nichols-Vinueza D; Dhroove G; Adams P; Chogle A
    Rev Gastroenterol Mex; 2013; 78(3):151-8. PubMed ID: 23948097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Brussels Infant and Toddler Stool Scale: A Study on Interobserver Reliability.
    Huysentruyt K; Koppen I; Benninga M; Cattaert T; Cheng J; De Geyter C; Faure C; Gottrand F; Hegar B; Hojsak I; Miqdady M; Osatakul S; Ribes-Koninckx C; Salvatore S; Saps M; Shamir R; Staiano A; Szajewska H; Vieira M; Vandenplas Y;
    J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):207-213. PubMed ID: 30672767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecograph: A graphical representation of daily stool forms to subtype irritable bowel syndrome in office practice.
    Shah C; Grover AS; Dhore P; Shukla A; Abraham P; Bhatia SJ
    JGH Open; 2019 Jun; 3(3):224-227. PubMed ID: 31276040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonic transit, bowel movements, stool form, and abdominal pain in irritable bowel syndrome by treatments with calcium polycarbophil.
    Chiba T; Kudara N; Sato M; Chishima R; Abiko Y; Inomata M; Orii S; Suzuki K
    Hepatogastroenterology; 2005; 52(65):1416-20. PubMed ID: 16201086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of pectin in the treatment of diarrhea predominant irritable bowel syndrome].
    Xu L; Yu W; Jiang J; Feng X; Li N
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Mar; 18(3):267-71. PubMed ID: 25809332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Modified Bristol Stool Form Scale: A Reliable and Valid Tool to Score Stool Consistency in Dutch (Non)Toilet-trained Toddlers.
    Wegh CAM; Hermes GDA; Schoterman MHC; Vaughan EE; Smidt H; Belzer C; Benninga MA
    J Pediatr Gastroenterol Nutr; 2021 Aug; 73(2):210-216. PubMed ID: 34402810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation to Polish, cross-cultural adaptation, and validation of the Bristol Stool Form Scale among healthcare professionals and patients.
    Wojtyniak K; Szajewska H; Dziechciarz P
    Prz Gastroenterol; 2018; 13(1):35-39. PubMed ID: 29657609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a new version of the Bristol Stool Form Scale: translation, content validity, face validity, and reliability of the Persian version.
    Shokouhi N; Mohammadi S; Ghanbari Z; Montazeri A
    BMJ Open Gastroenterol; 2022 Dec; 9(1):. PubMed ID: 36564095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of aquaporin 8 in colonic epithelium with diarrhoea-predominant irritable bowel syndrome.
    Wang JP; Hou XH
    Chin Med J (Engl); 2007 Feb; 120(4):313-6. PubMed ID: 17374283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized, placebo-controlled phase II study.
    Fukudo S; Matsueda K; Haruma K; Ida M; Hayase H; Akiho H; Nakashima Y; Hongo M
    Neurogastroenterol Motil; 2017 Jun; 29(6):. PubMed ID: 28205278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.